Lenvatinib Mesylate Intermediate CAS 205448-65-3 Purity>98.0% (HPLC) Factory

Kufotokozera Kwachidule:

Dzina la Mankhwala: Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate

CAS: 205448-65-3

Kuyera: > 98.0% (HPLC)

Maonekedwe: Woyera-Woyera mpaka Ufa Wachikasu

Pakati pa Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Chemical Properties:

Dzina la Chemical Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate
Mawu ofanana ndi mawu 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib Wapakati 3
Nambala ya CAS 205448-65-3
Nambala ya CAT Chithunzi cha RF-PI1973
Stock Status Mu Stock, Mphamvu Yopanga 50 MT / Chaka
Molecular Formula C12H11NO4
Kulemera kwa Maselo 233.22
Boiling Point 421.0±45.0℃
Kuchulukana 1.267±0.060 g/cm3
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Wachikasu
Kuyera / Kusanthula Njira >98.0% (HPLC)
Kutaya pa Kuyanika <1.00%
Zotsalira pa Ignition <0.50%
Zonse Zonyansa <2.00%
H-NMR Zimagwirizana ndi Kapangidwe
Test Standard Enterprise Standard
Kugwiritsa ntchito Pharmaceutical Intermediates

Phukusi & Kusungira:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi

Ubwino:

1

FAQ:

Ntchito:

Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) ndi yapakatikati ya Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, yogulitsidwa pansi pa dzina la Lenvima pakati pa ena, ndi mankhwala oletsa khansa pochiza mitundu ina ya khansa ya chithokomiro komanso makhansa ena.Inapangidwa ndi Eisai Co. ndipo imakhala ngati multiple kinase inhibitor motsutsana ndi VEGFR1, VEGFR2 ndi VEGFR3 kinases.Lenvatinib imavomerezedwa (kuyambira 2015) pochiza khansa ya chithokomiro yosiyana yomwe imakhala yobwerezabwereza kapena ya metastatic, yopita patsogolo, ndipo sanayankhe chithandizo cha radioactive ayodini (radioiodine).Mu Meyi 2016, bungwe la US Food and Drug Administration (FDA) lidavomereza (mophatikiza ndi everolimus) kuti azichiza matenda amtundu wa renal cell carcinoma kutsatira chithandizo chimodzi choyambirira cha anti-angiogenic.Mankhwalawa amavomerezedwanso ku US ndi ku European Union kwa hepatocellular carcinoma yomwe singathe kuchotsedwa opaleshoni kwa odwala omwe sanalandire chithandizo cha khansa pakamwa kapena jekeseni.

Lembani uthenga wanu apa ndikutumiza kwa ife